|
Résultats pour
marques
1.
|
IDERA
Numéro de série |
88631158 |
Statut |
Enregistrée |
Date de dépôt |
2019-09-25 |
Date d'enregistrement |
2020-12-15 |
Propriétaire |
Idera Pharmaceuticals, Inc. ()
|
Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, biologically active antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
|
2.
|
IDERA
Numéro d'application |
176194800 |
Statut |
Enregistrée |
Date de dépôt |
2016-01-05 |
Date d'enregistrement |
2019-07-26 |
Propriétaire |
Idera Pharmaceuticals, Inc. (USA)
|
Classes de Nice ? |
- 05 - Produits pharmaceutiques, vétérinaires et hygièniques
- 42 - Services scientifiques, technologiques et industriels, recherche et conception
|
Produits et services
(1) Medical therapeutic preparations, namely, nucleic acids as biologically active modulators, nucleic acids as biologically active immune modulators, biologically active antisense DNA and ribonucleic acid (RNA) compounds, chemical modulators of gene expression, namely reagents for DNA transcription, ribonucleic acid (RNA) and translation processes whereby a protein is synthesized from the information contained in a molecule of messenger RNA (mRNA); immunomodulatory oligonucleotides, namely, ingredients that enhance and induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral infections, bacterial infections, inflammatory disorders and inflammatory diseases, namely, anti-infectives and anti-inflammatories; pharmaceuticals for use in the treatment of asthma and allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection and diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents and cellular genes. (1) Medical research; scientific research in the field of genetics and genetic engineering; biological research in the field of genetics and genetic engineering; chemical research; medical and scientific research in the area of oligonucleotides and chemical products; pharmaceutical research services; pharmaceutical research and development; product research and development for others; biological and chemical research in the field of immunology.
|
3.
|
IDERA
Numéro d'application |
176201000 |
Statut |
Enregistrée |
Date de dépôt |
2016-01-05 |
Date d'enregistrement |
2019-07-26 |
Propriétaire |
Idera Pharmaceuticals, Inc. (USA)
|
Classes de Nice ? |
- 05 - Produits pharmaceutiques, vétérinaires et hygièniques
- 42 - Services scientifiques, technologiques et industriels, recherche et conception
|
Produits et services
(1) Medical therapeutic preparations, namely, nucleic acids as biologically active modulators, nucleic acids as biologically active immune modulators, biologically active antisense DNA and ribonucleic acid (RNA) compounds, chemical modulators of gene expression, namely reagents for DNA transcription, ribonucleic acid (RNA) and translation processes whereby a protein is synthesized from the information contained in a molecule of messenger RNA (mRNA); immunomodulatory oligonucleotides, namely, ingredients that enhance and induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral infections, bacterial infections, inflammatory disorders and inflammatory diseases, namely, anti-infectives and anti-inflammatories; pharmaceuticals for use in the treatment of asthma and allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection and diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents and cellular genes. (1) Medical and scientific research in the area of oligonucleotides and chemical products; pharmaceutical research and product development for others; biological and chemical research namely in the field of immunology.
(2) Medical research; scientific research in the field of genetics and genetic engineering; biological research in the field of genetics and genetic engineering; chemical research; medical and scientific research in the area of oligonucleotides and chemical products; pharmaceutical research services; pharmaceutical research and development; product research and development for others; biological and chemical research in the field of immunology.
|
4.
|
IDERA
Numéro d'application |
909240 |
Statut |
Enregistrée |
Date de dépôt |
2005-11-11 |
Date d'enregistrement |
2005-11-11 |
Propriétaire |
Idera Pharmaceuticals, Inc. (USA)
|
Classes de Nice ? |
- 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
- 05 - Produits pharmaceutiques, vétérinaires et hygièniques
- 42 - Services scientifiques, technologiques et industriels, recherche et conception
- 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
|
Produits et services
Reagents for the detection of polymerase chain reactions for
scientific or research use; diagnostic kits containing a
reagent for the detection of polymerase chain reactions for
scientific or research use; chemical products, namely,
synthetic oligonucleotides for use in the manufacture of
pharmaceuticals for modulating the immune system. Medical diagnostic and therapeutic preparations, namely,
biologically active modulators, including, immune modulators
and antisense DNA or RNA compounds, chemical modulators of
gene expression working at DNA transcription, RNA or
translation processes; immunomodulatory oligonucleotides
namely, ingredients that enhance or induce an immune
response as a component part in a pharmaceutical
preparation; pharmaceutical and vaccine adjuvants to enhance
the immune system response; pharmaceuticals for use in the
treatment of viral and bacterial infection, inflammatory
disorders and diseases, asthma or allergies, cancer, and
auto immune diseases and disorders and vaccine adjuvants to
modulate the immune system; biologically active compounds
for use in the treatment of viral and bacterial infection or
diseases associated with cellular gene expressions by
preventing the production of disease associated proteins
made by said infectious agents or cellular genes. Medical and scientific services namely provision of care in
the field of immunology (terms considered too vague by the
International Bureau (Rule 13(2)(b) of the Common
Regulations); medical and scientific research in the area of
oligonucleotides or chemical products; research and
development of pharmaceuticals and research products for
others; biological and/or chemical research namely in the
field of immunology. Medical services, namely, providing medical care in the
field of immunology.
|
5.
|
IDERA
Numéro d'application |
004739868 |
Statut |
Enregistrée |
Date de dépôt |
2005-11-15 |
Date d'enregistrement |
2007-02-23 |
Propriétaire |
Idera Pharmaceuticals, Inc. (USA)
|
Classes de Nice ? |
- 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
- 05 - Produits pharmaceutiques, vétérinaires et hygièniques
- 42 - Services scientifiques, technologiques et industriels, recherche et conception
- 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
|
Produits et services
Reagents for the detection of polymerase chain reactions for scientific or research use; diagnostic kits containing a reagent for the detection of polymerase chain reactions for scientific or research use; chemical products, namely, synthetic oligonucleotides for use in the manufacture of pharmaceuticals for modulating the immune system. Medical diagnostic and therapeutic preparations, namely, biologically active modulators, including, immune modulators and antisense DNA or RNA compounds, chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceutical for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes. Scientific services namely provision of care in the field of immunology; medical and scientific research in the area of oligonucleotides or chemical products; research and development of pharmaceuticals and research products for others; biological and/or chemical research namely in the field of immunology. Medical services, namely, provision of care in the field of immunology.
|
6.
|
IDERA
Numéro de série |
78660228 |
Statut |
Enregistrée |
Date de dépôt |
2005-06-28 |
Date d'enregistrement |
2007-12-04 |
Propriétaire |
IDERA PHARMACEUTICALS, INC. ()
|
Classes de Nice ? |
42 - Services scientifiques, technologiques et industriels, recherche et conception
|
Produits et services
Medical and scientific research in the area of oligonucleotides or chemical products; pharmaceutical research and product development for others; biological and chemical research namely in the field of immunology
|
7.
|
IDERA
Numéro de série |
78660224 |
Statut |
Enregistrée |
Date de dépôt |
2005-06-28 |
Date d'enregistrement |
2009-09-15 |
Propriétaire |
IDERA PHARMACEUTICALS, INC. ()
|
Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, [ biologically active antisense DNA or RNA compounds, ] chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
|
8.
|
IMO
Numéro de série |
78277138 |
Statut |
Enregistrée |
Date de dépôt |
2003-07-22 |
Date d'enregistrement |
2008-11-04 |
Propriétaire |
IDERA PHARMACEUTICALS, INC. ()
|
Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation
|
|